Suppr超能文献

长链非编码 RNA MALAT1 通过海绵吸附 miRNA-133a-3p 调控 PI3K/Akt/eNOS 通路从而靶向 IGF1R 表达,进而调节心肌缺血再灌注损伤。

Long non-coding RNA MALAT1 modulates myocardial ischemia-reperfusion injury through the PI3K/Akt/eNOS pathway by sponging miRNA-133a-3p to target IGF1R expression.

机构信息

Heart Center and Beijing Key Laboratory of Hypertension, Beijing Chaoyang Hospital, Capital Medical University, Beijing, 100020, China.

National Institute of Biological Sciences, Beijing, China.

出版信息

Eur J Pharmacol. 2022 Feb 5;916:174719. doi: 10.1016/j.ejphar.2021.174719. Epub 2021 Dec 27.

Abstract

The mechanism of myocardial ischemia-reperfusion injury (MIRI) is a complex pathophysiological process that can lead to poor patient outcomes. Although LncRNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) is reported to be highly expressed in myocardial ischemia reperfusion (IR) injury, the specific mechanism remains largely unknown. This study aimed to elucidate the roles and possible mechanism of MALAT1 in myocardial IR injury. IR model was established in rats by ligation of the anterior descending artery in vivo, and H9c2 and HL-1 cells were treated by hypoxia/reoxygenation (HR) to construct the model in vitro. The small interfering RNA (siRNA) for MALAT1 and miR-133a-3p mimics, inhibitor was used to transfect the cells. The expression of MALAT1, miR-133a-3p in MIRI were evaluated using real-time quantitative polymerase chain reaction (qRT-PCR),immunohistochemistry (IHC) and western blot (WB). Relationships between MALAT1, insulin-like growth factor 1 receptor (IGF1R) with miR-133a-3p were confirmed by luciferase reporter assay. Annexin V-FITC/PI double-labeled flow cytometry, terminal dexynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL), Cell Counting Kit-8 (CCK-8), serum creatine kinase MB (CK-MB), and lactate dehydrogenase (LDH) were evaluated to examine the impact of MALAT1 on MIRI. Our results revealed that MALAT1 was highly expressed, while miR-133a-3p and IGF1R were repressed in IR and HR groups. Knockdown of MALAT1 alleviate the pro-apoptotic effect and myocardial injury in vitro and in vivo. Systematically, MALAT1 may serve as a sponge for miR-133a-3p to suppress IGF1R, which a direct target of miR-133a-3p, then inhibit the PI3K/Akt/eNOS survival pathway. Mechanistically, our study demonstrated that MALAT1 regulates PI3K/Akt/eNOS signaling via miR-133a-3p. In summary, these results suggest that MALAT1 and miR-133a-3p play important roles in MIRI. MALAT1 regulates miR-133a-3p /IGF1R axis. These results show light on the underlying mechanisms of MIRI and provide potential therapeutic targets for MIRI.

摘要

心肌缺血再灌注损伤(MIRI)的机制是一个复杂的病理生理过程,可导致患者预后不良。虽然长链非编码 RNA 转移相关肺腺癌转录本 1(MALAT1)在心肌缺血再灌注(IR)损伤中被报道高表达,但具体机制仍知之甚少。本研究旨在阐明 MALAT1 在心肌 IR 损伤中的作用及其可能的机制。通过体内结扎前降支在大鼠中建立 IR 模型,并用缺氧/复氧(HR)处理 H9c2 和 HL-1 细胞在体外构建模型。用小干扰 RNA(siRNA)转染 MALAT1 和 miR-133a-3p 模拟物、抑制剂。实时定量聚合酶链反应(qRT-PCR)、免疫组织化学(IHC)和蛋白质印迹(WB)评估 MIRI 中 MALAT1、miR-133a-3p 的表达。通过荧光素酶报告基因检测证实 MALAT1、胰岛素样生长因子 1 受体(IGF1R)与 miR-133a-3p 之间的关系。用 Annexin V-FITC/PI 双标记流式细胞术、末端脱氧核苷酸转移酶介导的 dUTP 缺口末端标记(TUNEL)、细胞计数试剂盒-8(CCK-8)、血清肌酸激酶 MB(CK-MB)和乳酸脱氢酶(LDH)评估 MALAT1 对 MIRI 的影响。结果显示,IR 和 HR 组 MALAT1 表达升高,miR-133a-3p 和 IGF1R 表达下调。体外和体内敲低 MALAT1 可减轻促凋亡作用和心肌损伤。系统地说,MALAT1 可能作为 miR-133a-3p 的海绵,抑制 IGF1R,IGF1R 是 miR-133a-3p 的直接靶标,然后抑制 PI3K/Akt/eNOS 生存途径。机制上,本研究表明 MALAT1 通过 miR-133a-3p 调节 PI3K/Akt/eNOS 信号。总之,这些结果表明 MALAT1 和 miR-133a-3p 在 MIRI 中发挥重要作用。MALAT1 调节 miR-133a-3p/IGF1R 轴。这些结果揭示了 MIRI 的潜在机制,并为 MIRI 提供了潜在的治疗靶点。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验